TY - JOUR AU - Cardwell, Chris R. AU - Mc Menamin, Úna C. AU - Hicks, Blánaid M. AU - Hughes, Carmel AU - Cantwell, Marie M. AU - Murray, Liam J. PY - 2014 DA - 2014/02/13 TI - Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts JO - BMC Medicine SP - 28 VL - 12 IS - 1 AB - Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are commonly prescribed to the growing number of cancer patients (more than two million in the UK alone) often to treat hypertension. However, increased fatal cancer in ARB users in a randomized trial and increased breast cancer recurrence rates in ACEI users in a recent observational study have raised concerns about their safety in cancer patients. We investigated whether ACEI or ARB use after breast, colorectal or prostate cancer diagnosis was associated with increased risk of cancer-specific mortality. SN - 1741-7015 UR - https://doi.org/10.1186/1741-7015-12-28 DO - 10.1186/1741-7015-12-28 ID - Cardwell2014 ER -